Ciloxan (Ciprofloxacin HCl ophthalmic ointment), 0.3% Alcon NDA 20-369/S6 & S7 8/19/03 8/28/03 8/28/03 Ciloxan/ciprofloxacin HCl ophthalmic ointment Alcon NDA 20-369 Cipro HC Otic/Ciprofloxacin Hydrochloride & Hydrocortisone Otic Suspension, Bayer NDA 20-805 2/10/98 1/7/99 1/7/99 1/7/99 Cipro XR (ciprofloxacin) Extended-Release Tablets, 1g, Bayer NDA 21-554 8/27/03 09/09/03 09/09/03 Cipro XR (ciprofloxacin) Extended-Release Tablets, 500 mg, Bayer NDA 21-473 12/13/02 1/30/03 12/16/02 10/9/03 Cipro (ciprofloxacin hydrochloride) Tablets, Bayer NDA 19-537/S-043 12/13/02 1/29/03 Cipro (Ciprofloxacin Hydrochloride) Tablets & Cipro (ciprofloxacin) Suspension, 5% and 10%, Bayer , Pharmaceutical Division NDA 19-537/S41 & 20-780/S11 4/17/02 4/22/02 4/18/02 Cipro (Ciprofloxacin) IV Solution, Bayer , Pharmaceutical Division NDA 19-847/S026, 19-857/S028 & 19-858/S022 4/17/02 4/22/02 4/18/02 Cipro (Ciprofloxacin Hydrochloride) Tablets, IV Solution, IV in 5% Dextrose, IV in 0.9% Saline, & Suspension, Bayer , Pharmaceutical Division NDA 19-537/S038, 19-847/S024, 19-857/S027, 19-858/S021, 20-780/S008 8/30/00 9/7/00 9/7/00 10/16/01 CIPRODEX (ciprofloxacin 0.3% and dexamethasone 0.1% ) Sterile Otic Suspension, Alcon Research, Ltd. NDA 21-537 7/18/03 7/28/03 Ciprofloxacin Ophthalmic Solution USP, 0.3%, Tentatively Approved Novex Pharma ANDA 75-928 2/4/02 4/10/03 Ciprofloxacin Tablets USP, 250 mg, 500, and 750 mg, Tentatively Approved Technilab Pharma, ANDA 76-138 9/11/02 Ciprofloxacin Tablets USP, 250 mg, 500, and 750 mg, Tentatively Approved Teva USA ANDA 76-136 12/26/01 4/16/03 Ciprofloxacin Tablets USP, 250 mg, 500, and 750 mg, Tentatively Approved Carlsbad Technology, ANDA 76-126 8/14/02 Ciprofloxacin Tablets USP, 100 mg, 250 mg, 500, and 750 mg, Tentatively Approved IVAX ANDA 76-089 9/25/03 Ciprofloxacin Tablets USP, 100 mg, 250 mg, 500, and 750 mg, Tentatively Approved 5/30/01 Geneva ANDA 75-939 5/30/01 6/5/01 Ciprofloxacin Tablets USP, 100 mg, 250 mg, 500, and 750 mg, Tentatively Approved 8/31/01 Genpharm ANDA 75-817 8/31/01 4/15/03 Ciprofloxacin Tablets USP, 250 mg, 500, and 750 mg, Tentatively Approved 3/30/01 Ranbaxy ANDA 75-747 3/30/01 3/30/01 Ciprofloxacin Tablets USP, 250, 500 & 750 mg, Tentatively Approved 7/18/01 Mylan ANDA 75-685 7/18/01 Ciprofloxacin Tablets USP,750 mg, Tentatively Approved 3/30/00 Mylan ANDA 75-685 3/30/00 4/4/00 Ciprofloxacin Tablets USP, 100 mg, 250 mg, 500, and 750 mg, Tentatively Approved 8/22/02 Dr. Reddy's Ltd. ANDA 75-593 8/22/02 Ciprofloxacin Tablets USP, 250 mg, 500 mg, 500 mg, and 750 mg, Tentatively Approved 3/24/99 Novopharm ANDA 74-876 CIPROFLOXACIN For Suspension; 250MG/5ML CIPRO BAYER 020780 CIPROFLOXACIN For Suspension; 500MG/5ML CIPRO BAYER 019847 CIPROFLOXACIN Injection 10MG/ML CIPRO BAYER 019857 CIPROFLOXACIN Injection 200MG/100ML CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER BAYER 020369 CIPROFLOXACIN HYDROCHLORIDE Ointment; Ophthalmic 0.3% BASE CILOXAN ALCON 019992 CIPROFLOXACIN HYDROCHLORIDE Solution/Drops; Ophthalmic 0.3% BASE CILOXAN ALCON 019537 CIPROFLOXACIN HYDROCHLORIDE Tablet; 100MG BASE CIPRO BAYER 019537 CIPROFLOXACIN HYDROCHLORIDE Tablet; 250MG BASE CIPRO BAYER 019537 CIPROFLOXACIN HYDROCHLORIDE Tablet; 500MG BASE CIPRO BAYER 019537 CIPROFLOXACIN HYDROCHLORIDE Tablet; 750MG BASE CIPRO BAYER 020805 CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE Suspension/Drops; Otic 0.2% BASE;1% CIPRO HC ALCON 021473 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE Tablet, Extended Release; 212.6MG;EQ 287.5MG BASE CIPRO XR BAYER 021473 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE Tablet; 425.2MG;EQ 574.9MG BASE CIPRO XR BAYER 021537 CIPROFLOXACIN; DEXAMETHASONE Suspension/Drops; Otic 0.3%;0.1% CIPRODEX ALCON